Ranitidine
Ranitidine is a pharmaceutical drug with 39 clinical trials. Historical success rate of 86.1%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
6
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.6%
31 of 38 finished
18.4%
7 ended early
0
trials recruiting
39
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Clinical Trials (39)
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia
Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration
Bronchial Hyper-responsiveness in Reflux Cough
A Study of LY2090314 in Patients With Advanced or Metastatic Cancer
TPI 287 in Breast Cancer Metastatic to the Brain
A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult Participants
Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering
Ranitidin Versus Omeprazole in Patients Taking Clopidogrel
Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer
A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers
The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux
Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA
Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 39